PUBLISHER: The Business Research Company | PRODUCT CODE: 1760506
PUBLISHER: The Business Research Company | PRODUCT CODE: 1760506
Coil transcatheter embolization and occlusion devices are minimally invasive medical devices designed to block (embolize) blood flow in a vessel or abnormal vascular structure. These devices are typically small metal coils that are delivered via a catheter through the vascular system to the target site.
The product types of coil transcatheter embolization and occlusion devices include detachable coils, pushable coils, and others. Detachable coils are implantable devices used in minimally invasive procedures to block blood flow in aneurysms or abnormal blood vessels, allowing for precise placement through a catheter once the target site is confirmed. These devices are applied in various procedures, including hemorrhage control, vascular occlusion, aneurysm treatment, tumor embolization, and others. They are made from materials such as platinum or platinum alloys, nickel titanium (nitinol), stainless steel, and others. Key end users of these devices include hospitals, ambulatory surgical centers (ASCs), specialty clinics, and research and academic institutions.
The coil transcatheter embolization and occlusion devices market research report is one of a series of new reports from The Business Research Company that provides coil transcatheter embolization and occlusion devices market statistics, including the coil transcatheter embolization and occlusion devices industry's global market size, regional shares, competitors with the coil transcatheter embolization and occlusion devices market share, detailed coil transcatheter embolization and occlusion devices market segments, market trends and opportunities, and any further data you may need to thrive in the coil transcatheter embolization and occlusion devices market. This coil transcatheter embolization and occlusion devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The coil transcatheter embolization and occlusion devices market size has grown strongly in recent years. It will grow from $1.64 billion in 2024 to $1.78 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth during the historic period can be attributed to factors such as the growing demand for image-guided procedures, expanding applications in trauma care, increased investments in interventional radiology, the rising use of embolization in gastrointestinal bleeding management, and the growing approvals of novel coil designs.
The coil transcatheter embolization and occlusion devices market size is expected to see strong growth in the next few years. It will grow to $2.40 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The projected growth during the forecast period is driven by factors including the increasing prevalence of aneurysms, a rising adoption of minimally invasive procedures, a growing geriatric population, an increasing incidence of cancer, and rising healthcare expenditure. Key trends in the forecast period include advancements in detachable coil technology, the integration of microcatheters with enhanced flexibility, technological developments in imaging guidance systems, advancements in bioactive and coated coil materials, and the integration of real-time 3D imaging.
The growing emphasis on personalized medicine is expected to drive the expansion of the coil transcatheter embolization and occlusion devices market. Personalized medicine tailors healthcare decisions and treatments based on an individual's genetic makeup, lifestyle, and environment. The rise in personalized medicine is largely due to advancements in genomic sequencing, which have made it more affordable and accessible to customize treatments according to genetic profiles. Coil transcatheter embolization and occlusion devices contribute to the advancement of personalized medicine by enabling precise, patient-specific treatments. Using advanced imaging, these devices are adapted to an individual's vascular anatomy, allowing for targeted treatment of abnormal blood vessels or tumors while minimizing damage to healthy tissue. For example, in 2022, the Personalized Medicine Coalition reported that 12 new personalized medicines accounted for approximately 34% of all new therapies approved, a notable increase from previous years. As a result, the growing emphasis on personalized medicine is fueling the market for coil transcatheter embolization and occlusion devices.
Leading companies in the coil transcatheter embolization and occlusion devices market are focusing on creating advanced products, such as medical implants, to improve precision, reduce procedure time, and support minimally invasive treatments. These advanced medical implants are long-term devices surgically placed inside the body to replace, support, or enhance biological functions, often incorporating technologies such as sensors, electronics, or drug delivery systems. For instance, in March 2022, Artio Medical Inc., a US-based company, received FDA 510(k) clearance for its Solus Gold Embolization Device. This next-generation device is designed for peripheral vascular occlusion, helping to address the limitations of existing devices, particularly in challenging anatomical cases.
In January 2025, Kaneka Corporation, a Japan-based chemical manufacturer, acquired EndoStream Medical Ltd., a company specializing in coil transcatheter embolization and occlusion devices for brain aneurysm treatment. This acquisition strengthens Kaneka's neurovascular portfolio, particularly by integrating EndoStream's innovative technologies, such as the Nautilus device for wide-neck cerebral aneurysms. Kaneka aims to use this acquisition to accelerate the development and global distribution of advanced coil embolization solutions.
Major players in the coil transcatheter embolization and occlusion devices market are Johnson and Johnson, Abbott Laboratories, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Terumo Medical Corporation, Kaneka Corporation, Cook Medical LLC, Merit Medical Systems Inc., Penumbra Inc., MicroVention Inc., Asahi Intecc Co. Ltd., Balt Extrusion SAS, Phenox GmbH, Acandis GmbH & Co. KG, B. Braun Interventional Systems Inc., EndoShape Inc., Shape Memory Medical Inc., Artio Medical Inc., Medico's Hirata Inc.
North America was the largest region in the coil transcatheter embolization and occlusion devices market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in coil transcatheter embolization and occlusion devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the coil transcatheter embolization and occlusion devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The coil transcatheter embolization and occlusion devices market consists of sales of hydrogel-coated coils, fibered coils, and neurovascular coils. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Coil Transcatheter Embolization And Occlusion Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on coil transcatheter embolization and occlusion devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for coil transcatheter embolization and occlusion devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The coil transcatheter embolization and occlusion devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Subsegments